The effect of bendroflumethiazide on the renal handling of calcium, magnesium and phosphate in normocalcaemic renal stone formers and in hyperparathyroidism.
D000042:Absorption; D000328:Adult; D000368:Aged; D001539:Bendroflumethiazide; D001798:Blood Proteins; D002118:Calcium / Q000097:blood / Q000652:urine*; D002245:Carbon Dioxide / Q000097:blood; D002712:Chlorides / Q000097:blood; D003404:Creatinine / Q000652:urine; D005260:Female; D006801:Humans; D006934:Hypercalcemia / Q000378:metabolism; D006961:Hyperparathyroidism / Q000378:metabolism*; D007668:Kidney / Q000187:drug effects; D007669:Kidney Calculi / Q000378:metabolism*; D008274:Magnesium / Q000097:blood / Q000652:urine*; D008297:Male; D008875:Middle Aged; D010710:Phosphates / Q000097:blood / Q000652:urine*; D011188:Potassium / Q000378:metabolism; D012964:Sodium / Q000652:urine
D001798:Blood Proteins; D002712:Chlorides; D010710:Phosphates; D002245:Carbon Dioxide; D001539:Bendroflumethiazide; D012964:Sodium; D003404:Creatinine; D008274:Magnesium; D011188:Potassium; D002118:Calcium